PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas

被引：2
作者：
Lisi, Lucia [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, IRCSS Fdn Policlin Univ Agostino Gemelli, Dipartimento Sicurezza & Bioet, Largo Francesco Vito 1, Rome 00168, Italy
来源：
TRANSLATIONAL CANCER RESEARCH | 2020年 / 9卷 / 04期
关键词：
NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II TRIAL; TEMOZOLOMIDE; RADIOTHERAPY;
D O I：
10.21037/tcr.2020.02.72
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2161 / 2163
页数：3
相关论文
共 16 条
  • [1] Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
    Cairncross, Gregory
    Wang, Meihua
    Shaw, Edward
    Jenkins, Robert
    Brachman, David
    Buckner, Jan
    Fink, Karen
    Souhami, Luis
    Laperriere, Normand
    Curran, Walter
    Mehta, Minesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 337 - 343
  • [2] Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
    Chang, SM
    Wen, P
    Cloughesy, T
    Greenberg, H
    Schiff, D
    Conrad, C
    Fink, K
    Robins, HI
    De Angelis, L
    Raizer, J
    Hess, K
    Aldape, K
    Lamborn, KR
    Kuhn, J
    Dancey, J
    Prados, MD
    [J]. INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 357 - 361
  • [3] A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
    Jenkins, Robert B.
    Blair, Hilary
    Ballman, Karla V.
    Giannini, Caterina
    Arusell, Robert M.
    Law, Mark
    Flynn, Heather
    Passe, Sandra
    Felten, Sara
    Brown, Paul D.
    Shaw, Edward G.
    Buckner, Jan C.
    [J]. CANCER RESEARCH, 2006, 66 (20) : 9852 - 9861
  • [4] Molecular targeted therapy of glioblastoma
    Le Rhun, Emilie
    Preusser, Matthias
    Roth, Patrick
    Reardon, David A.
    van den Bent, Martin
    Wen, Patrick
    Reifenberger, Guido
    Weller, Michael
    [J]. CANCER TREATMENT REVIEWS, 2019, 80
  • [5] Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
    Lisi, L.
    Ciotti, G. M. P.
    Braun, D.
    Kalinin, S.
    Curro, D.
    Dello Russo, C.
    Coli, A.
    Mangiola, A.
    Anile, C.
    Feinstein, D. L.
    Navarra, P.
    [J]. NEUROSCIENCE LETTERS, 2017, 645 : 106 - 112
  • [6] Phospho-mTOR expression in human glioblastoma microglia-macrophage cells
    Lisi, Lucia
    Ciotti, Gabriella Maria Pia
    Chiavari, Marta
    Pizzoferrato, Michela
    Mangiola, Annunziato
    Kalinin, Sergey
    Feinstein, Douglas L.
    Navarra, Pierluigi
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 129
  • [7] The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype
    Lisi, Lucia
    Laudati, Emilia
    Navarra, Pierluigi
    Dello Russo, Cinzia
    [J]. JOURNAL OF NEUROINFLAMMATION, 2014, 11
  • [8] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    Louis, David N.
    Perry, Arie
    Reifenberger, Guido
    von Deimling, Andreas
    Figarella-Branger, Dominique
    Cavenee, Webster K.
    Ohgaki, Hiroko
    Wiestler, Otmar D.
    Kleihues, Paul
    Ellison, David W.
    [J]. ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 803 - 820
  • [9] A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
    Ma, Daniel J.
    Galanis, Evanthia
    Anderson, S. Keith
    Schiff, David
    Kaufmann, Timothy J.
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Flynn, Patrick J.
    Ligon, Keith L.
    Buckner, Jan C.
    Sarkaria, Jann N.
    [J]. NEURO-ONCOLOGY, 2015, 17 (09) : 1261 - 1269
  • [10] Brain Tumors Across the Age Spectrum: Biology, Therapy, and Late Effects
    Merchant, Thomas E.
    Pollack, Ian F.
    Loeffler, Jay S.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (01) : 58 - 66
12